Ads
related to: boston scientific apollo endosurgery
Search results
Results From The WOW.Com Content Network
Stephens has reiterated an Overweight rating for Apollo Endosurgery Inc (NASDAQ: APEN) while increasing the price target from $8 to $9. "In our opinion, APEN's valuation does not assign full value ...
Apollo Endosurgery, Inc. (APEN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.23 per share a year ago.
The consensus price target hints at a 35.4% upside potential for Apollo Endosurgery, Inc. (APEN). While empirical research shows that this sought-after metric is hardly effective, an upward trend ...
Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware, [2] is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular ...
Pasricha has help found a number of companies in the medical and gastroenterology spaces, including Apollo Endosurgery, an endoscopic devices company co-developed with Peter B. Cotton, that forms part of Boston Scientific. [9] [10]
Kenneth Frank Binmoeller is a medical doctor and author of multiple scientific contributions [1] and over 300 publications, [2] [3] as well as the inventor of the lumen-apposing metal stent (LAMS) [4] [5] and AXIOS System. [6] [7] These are medical devices used to relieve blockages while creating a direct connection between two bodily ...
Apollo Endosurgery, Inc. (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
A single-use rotatable endoclip in packaging. An endoclip is a metallic mechanical device used in endoscopy in order to close two mucosal surfaces without the need for surgery and suturing.